Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.21.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Mar. 31, 2020
Current Assets:    
Cash and cash equivalents $ 49,533 $ 15,068
Accounts receivable, net of allowances of $314 at March 31, 2021 and $703 at March 31, 2020 20,593 16,240
Inventories, net 11,829 21,460
Prepaid expenses and other current assets 4,953 3,987
Total current assets 86,908 56,755
Property, plant, equipment and rental assets, net 9,630 7,749
Non-current portion of inventories 1,845 1,221
Other assets 7,639 8,230
Total assets 106,022 73,955
Current Liabilities:    
Accounts payable and accrued expenses 19,767 15,000
Accrued salaries and wages 1,889 1,644
Accrued warranty reserve 5,850 1,934
Deferred revenue 6,374 7,898
Current portion of notes payable and lease obligations 576 477
Total current liabilities 34,456 26,953
Deferred revenue - non-current 765 944
Term note payable, net 52,865 27,963
Long-term portion of notes payable and lease obligations 4,762 5,074
Total liabilities 92,848 60,934
Commitments and contingencies (Note 12)
Stockholders’ Equity:    
Preferred stock, $.001 par value; 1,000,000 shares authorized; none issued
Common stock, $.001 par value; 51,500,000 shares authorized, 12,898,144 shares issued and 12,824,190 shares outstanding at March 31, 2021; 10,286,366 shares issued and 10,228,789 shares outstanding at March 31, 2020 13 10
Additional paid-in capital 934,381 915,755
Accumulated deficit (919,271) (900,869)
Treasury stock, at cost; 73,954 shares at March 31, 2021 and 57,577 shares at March 31, 2020 (1,949) (1,875)
Total stockholders’ equity 13,174 13,021
Total liabilities and stockholders' equity $ 106,022 $ 73,955